FIRST CHECK HOME DRUG TEST FOR MDMA (ECSTASY)— 510(k) K020869

Name: FDA 510(k) clearance K020869
Creator: U.S. Food and Drug Administration
Published: 2002-06-11

Substantially Equivalent

Worldwide Medical Corp.

FDA 510(k) clearance K020869 for FIRST CHECK HOME DRUG TEST FOR MDMA (ECSTASY), Substantially Equivalent on 2002-06-11. Applicant: Worldwide Medical Corp.. Device class: 2.

Clearance details

Applicant: Worldwide Medical Corp.
Product code: Code DKZ
Device class: Class 2
Regulation: 21 CFR 862.3100
Advisory panel: Clinical Toxicology
Date received: 2002-03-18
Decision date: 2002-06-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Lake Forest, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DKZ

view all

K240670 — DRI Ecstasy Plus Assay2024-10-30
K233019 — AllTest Multi-Drug Rapid Test Cup +3 more2023-12-13
K231137 — Xenta Drug Screen Cup, Xenta Drug Screen Dipcard2023-05-19
K200363 — Quidel Triage® TOX Drug Screen, 946002020-03-11
K191099 — Atlas Multi-Drugs Screening Test Cup, Atlas Multi-Drugs Screening Test Panel2019-10-03

More clearances from Worldwide Medical Corp.

view all

K993852 — FIRST CHECK HOME DRUG TEST PANEL 42000-11-29
K993663 — FIRST CHECK HOME DRUG TEST (THC)2000-06-23
K994138 — FIRST CHECK HOME DRUG TEST PANEL 32000-06-23
K994139 — FIRST CHECK HOME DRUG TEST PANEL 22000-06-23

Data sourced from openFDA. This site is unofficial and independent of the FDA.